Fundamental and Clinical Pharmacology

2.6(top 20%)

impact factor

2.7K(top 10%)

papers

50.8K(top 10%)

citations

89(top 5%)

h-index

2.7(top 20%)

impact factor

3.4K

all documents

53.1K

doc citations

129(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update	Fundamental and Clinical Pharmacology	2005	920
2	The Hill equation: a review of its capabilities in pharmacological modelling	Fundamental and Clinical Pharmacology	2008	645
3	Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review	Fundamental and Clinical Pharmacology	2006	352
4	Animal models of neuropathic pain	Fundamental and Clinical Pharmacology	2011	283
5	The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning	Fundamental and Clinical Pharmacology	2005	269
6	Research review on the pharmacological effects of astragaloside IV	Fundamental and Clinical Pharmacology	2017	258
7	Drug‐induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies	Fundamental and Clinical Pharmacology	2008	251
8	Tissue injury by reactive oxygen species and the protective effects of flavonoids	Fundamental and Clinical Pharmacology	1998	250
9	Modulation of neurotransmitter release via histamine H₃ heteroreceptors	Fundamental and Clinical Pharmacology	1994	246
10	Dopamine, depression and antidepressants	Fundamental and Clinical Pharmacology	2004	244
11	Clinical pharmacology in the geriatric patient	Fundamental and Clinical Pharmacology	2007	242
12	Gastrointestinal absorption of drugs: methods and studies	Fundamental and Clinical Pharmacology	1999	233
13	Gender and the renin–angiotensin–aldosterone system	Fundamental and Clinical Pharmacology	2010	217
14	Animal models of anxiety in mice	Fundamental and Clinical Pharmacology	2007	203
15	Herb-drug interactions: an overview of the clinical evidence	Fundamental and Clinical Pharmacology	2005	197
16	The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery	Fundamental and Clinical Pharmacology	2008	197
17	Ginkgo biloba extracts and cancer: a research area in its infancy	Fundamental and Clinical Pharmacology	2003	194
18	Role of 5‐HT_1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies	Fundamental and Clinical Pharmacology	1996	190
19	Distinct isoforms (COX‐1 and COX‐2) of cyclooxygenase: possible physiological and therapeutic implications	Fundamental and Clinical Pharmacology	1996	187
20	Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life	Fundamental and Clinical Pharmacology	2004	170
21	Drugs and their molecular targets: an updated overview	Fundamental and Clinical Pharmacology	2008	170
22	The efficacy of herbal medicine - an overview	Fundamental and Clinical Pharmacology	2005	168
23	Pharmacogenetics of the major polymorphic metabolizing enzymes	Fundamental and Clinical Pharmacology	2003	167
24	Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans	Fundamental and Clinical Pharmacology	2005	167
25	Phytol, a diterpene alcohol, inhibits the inflammatory response by reducing cytokine production and oxidative stress	Fundamental and Clinical Pharmacology	2014	161
26	Drug metabolism and disposition in children	Fundamental and Clinical Pharmacology	2003	160
27	Invited review: the evolution of antidepressant mechanisms	Fundamental and Clinical Pharmacology	2004	158
28	Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension	Fundamental and Clinical Pharmacology	2008	153
29	Metabolic drug interactions with new psychotropic agents	Fundamental and Clinical Pharmacology	2003	152
30	Analysis of drug transporter expression in human intestinal Caco‐2 cells by real‐time PCR	Fundamental and Clinical Pharmacology	2007	149
31	The therapeutic potential of NO-NSAIDs	Fundamental and Clinical Pharmacology	2003	147
32	Emerging trends of nanomedicine – an overview	Fundamental and Clinical Pharmacology	2009	143
33	Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in mice	Fundamental and Clinical Pharmacology	2009	142
34	Serotonin syndrome: history and risk	Fundamental and Clinical Pharmacology	1998	141
35	PREVENTION OF CCL₄‐INDUCED LIVER CIRRHOSIS BY SILYMARIN	Fundamental and Clinical Pharmacology	1989	140
36	Pharmacoepidemiology of anabolic androgenic steroids: a review	Fundamental and Clinical Pharmacology	2005	139
37	Gastrointestinal effects of nonsteroidal anti-inflammatory drugs	Fundamental and Clinical Pharmacology	2003	135
38	Opioid and anti‐opioid peptides	Fundamental and Clinical Pharmacology	1995	131
39	Treatment perspectives for human African trypanosomiasis	Fundamental and Clinical Pharmacology	2003	128
40	Current and future therapy in Alzheimer’s disease	Fundamental and Clinical Pharmacology	2008	128
41	Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies	Fundamental and Clinical Pharmacology	2000	124
42	Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans	Fundamental and Clinical Pharmacology	2004	124
43	Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test	Fundamental and Clinical Pharmacology	2003	122
44	Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes	Fundamental and Clinical Pharmacology	2004	120
45	Mechanisms of hypokalemia‐induced ventricular arrhythmogenicity	Fundamental and Clinical Pharmacology	2010	119
46	Potassium channel openers: pharmacological and clinical aspects	Fundamental and Clinical Pharmacology	1992	117
47	The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum	Fundamental and Clinical Pharmacology	2003	117
48	Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo	Fundamental and Clinical Pharmacology	2013	116
49	A randomized, double‐blind, multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children	Fundamental and Clinical Pharmacology	1996	115
50	Dopamine agonists in Parkinson's disease: a look at apomorphine	Fundamental and Clinical Pharmacology	1993	113

Scientometrics

Overviews

Citing Bodies

Fundamental and Clinical Pharmacology

Top Articles